- Home
- PRFX vs FOXO Comparison
PRFX vs FOXO Comparison
Compare PRFX & FOXO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRFX
- FOXO
- Stock Information
- Founded
- PRFX 2007
- FOXO 2019
- Country
- PRFX Israel
- FOXO United States
- Employees
- PRFX N/A
- FOXO 168
- Industry
- PRFX Biotechnology: Pharmaceutical Preparations
- FOXO Retail: Computer Software & Peripheral Equipment
- Sector
- PRFX Health Care
- FOXO Technology
- Exchange
- PRFX Nasdaq
- FOXO Nasdaq
- Market Cap
- PRFX 3.8M
- FOXO 3.9M
- IPO Year
- PRFX 2020
- FOXO N/A
- Fundamental
- Price
- PRFX $2.32
- FOXO $0.08
- Analyst Decision
- PRFX Hold
- FOXO
- Analyst Count
- PRFX 1
- FOXO 0
- Target Price
- PRFX N/A
- FOXO N/A
- AVG Volume (30 Days)
- PRFX 3.8M
- FOXO 7.4M
- Earning Date
- PRFX 05-14-2025
- FOXO 04-15-2025
- Dividend Yield
- PRFX N/A
- FOXO N/A
- EPS Growth
- PRFX N/A
- FOXO N/A
- EPS
- PRFX N/A
- FOXO N/A
- Revenue
- PRFX N/A
- FOXO $4,051,601.00
- Revenue This Year
- PRFX N/A
- FOXO N/A
- Revenue Next Year
- PRFX N/A
- FOXO N/A
- P/E Ratio
- PRFX N/A
- FOXO N/A
- Revenue Growth
- PRFX N/A
- FOXO 2688.61
- 52 Week Low
- PRFX $0.43
- FOXO $0.07
- 52 Week High
- PRFX $16.63
- FOXO $1.30
- Technical
- Relative Strength Index (RSI)
- PRFX 51.08
- FOXO 27.54
- Support Level
- PRFX $1.92
- FOXO $0.07
- Resistance Level
- PRFX $2.37
- FOXO $0.12
- Average True Range (ATR)
- PRFX 0.27
- FOXO 0.01
- MACD
- PRFX 0.07
- FOXO -0.00
- Stochastic Oscillator
- PRFX 35.36
- FOXO 17.72
About PRFX PainReform Ltd.
PainReform Ltd is a clinical-stage specialty pharmaceutical company. It is focused on the reformulation of established therapeutics. The company's product PRF-110 is based on the local anesthetic ropivacaine, targeting the post-operative pain relief market. PRF-110 is an oil-based, viscous, clear solution that is deposited directly into the surgical wound bed before closure to provide localized and extended post-operative analgesia.
About FOXO FOXO Technologies Inc.
FOXO Technologies Inc is a technology platform company focused on commercializing longevity science through products and services that serve the life insurance industry. FOXO's epigenetic technology applies AI to DNA methylation to identify molecular biomarkers of human health and aging. The company has two reportable business segments, FOXO Labs and FOXO Life.